What a legitimate peptide prescription looks like, and the red flags

Do you need a prescription for peptides?

For the peptides that are approved drugs, yes. Semaglutide, tirzepatide, teriparatide, leuprolide and dozens of others are prescription medicines in the US, dispensed by a licensed pharmacy on a valid prescription. Our encyclopedia marks each entry's approval status, dated to when we last checked it: as of October 4, 2026, 114 of its 349 entries are marked FDA-approved, from GLP-1 drugs to hormone-blocking injections for prostate cancer and the radioligand cancer treatments.

For the many peptides that are not approved, the question is different. There is no legal way to sell them for human use, and a prescription does not create one. A doctor can write a prescription for almost anything, but a pharmacy may only fill it with an approved product or with a compounded drug made under the rules for compounding pharmacies, and several popular peptides are on FDA's list of substances that raise safety concerns for compounding. Our guide to Category 2, 503A and 503B explains those lists, and our BPC-157 prescription article works through one case in detail.

Products sold as "research use only" sit outside both routes. They are not prescriptions, whatever the seller's website implies.

What a legitimate prescription looks like

A legitimate prescription is the end of a medical process, not a purchase. It starts with an assessment: a clinician takes a history, reviews your conditions and other medicines, and for many peptide drugs orders tests, such as blood sugar and kidney function before a GLP-1 drug or hormone levels before a gonadotropin-releasing hormone analogue. It ends with a decision that may be no, and a service that has never been known to say no to anyone is not making medical decisions at all.

The prescription itself names you, the drug, its strength and form, the dose and how often to take it, how much to dispense and how many refills, and the prescriber, with credentials you can check. State medical, nursing and physician-assistant boards publish licence lookups, so you can confirm the prescriber is licensed where you live.

Follow-up is part of it, and so is honesty about cost and duration. Approved peptides such as GLP-1 drugs are started at low doses and stepped up over weeks, with checks for side effects along the way, and the US labels spell out that schedule. A service that sends a three-month supply with no plan to hear from you again is not practising medicine in any meaningful sense.

Checking the pharmacy

FDA's BeSafeRx campaign sets out what a safe online pharmacy does: it always requires a prescription, is licensed by your state board of pharmacy, gives a physical address and telephone number in the United States, and has a pharmacist available to answer questions (government guidance) ¹. You can confirm the licence yourself in your state board's online database; BeSafeRx links to each state's lookup. It takes a few minutes and is the single most useful check you can make, because an illegal pharmacy can copy a licensed one's logo and wording but not its entry in the state register.

FDA's warning signs are the mirror image: a site that sells prescription drugs without a prescription, offers prices that look too good to be true, sends unsolicited email, is based outside the US, or is not licensed in the US. Packaging that differs from what a local pharmacy dispenses, is damaged or in a foreign language, or has no expiry date is another sign (government guidance) ¹.

The scale of the problem is measurable. When researchers searched for semaglutide online in 2023, 42% of the links leading to online pharmacies went to illegal sites; test purchases from them produced vials with semaglutide purity of 7.7% to 14.4% against the 99% claimed and endotoxin in every sample, while the prefilled pens ordered never arrived (market surveillance study) ².

Reading the label

A branded drug arrives in the manufacturer's packaging with a pharmacy label carrying your name, the drug, dose and directions, the prescriber and the pharmacy's details. A compounded drug has no manufacturer's packaging, so its label is the main record of what it is.

Compounded products made in an outsourcing facility, the larger compounders registered with FDA under section 503B, must carry the statement "This is a compounded drug" on the label, along with the facility's name, the date the drug was compounded and other details set out in the law (statute) ³. Products made by a traditional compounding pharmacy for an individual patient under section 503A are labelled under state pharmacy rules, but should still name the active ingredient, its strength and the pharmacy.

What a label should never say is "for research use only" on something you were told to inject. That phrase means the product was not made or sold as a medicine at all.

How telehealth changes the rules

Telehealth is legal and widely used for peptide drugs, including GLP-1 medicines. The rules that matter most are about licensing: in most states a clinician needs a licence in the state where the patient is during the visit, and telehealth care is held to the same standard as an office visit.

The federal law people most often cite, the Ryan Haight Act, applies only to controlled substances, where it generally requires an in-person evaluation before prescribing over the internet. Since 2020, temporary rules from the DEA and HHS have suspended that requirement; the fourth extension runs from January 1 to December 31, 2026, while permanent rules are developed (regulation) ⁴. Most peptide drugs, including the GLP-1 medicines, are not controlled substances, so this law does not decide whether a telehealth prescription for them is legitimate. Licensing, a real assessment and a licensed pharmacy do.

A legitimate telehealth service looks much like a clinic: it collects a proper medical history, reviews recent test results or orders new ones, uses video when the decision warrants it, names the clinician, and lets you reach someone if problems arise.

The red flags

• A "prescription" issued after a short online form, with no clinician you can name or speak to.
• Offers to prescribe or compound peptides that are not approved, such as BPC-157, TB-500 or retatrutide.
• "Research use only" products shipped with dosing instructions or injection supplies.
• A pharmacy you cannot find in your state board of pharmacy's licence database, or with no US address.
• Prices far below what licensed pharmacies charge for the same drug, or payment only by cryptocurrency or gift card.
• No follow-up plan, no questions about your other medicines, and no warning about side effects.
• Claims that a peptide is "FDA registered" or "FDA compliant", phrases that do not mean approved.

Our article on 12 questions to ask a peptide clinic turns these into questions to put to a provider before paying, and our legal status checker shows where each compound stands.

Compounded is not the same as approved

Compounding has a legitimate role: making a medicine in a form or strength that is not commercially available, for a patient who needs it. During drug shortages, FDA allowed compounders to make copies of GLP-1 drugs, and that is how many people first got compounded semaglutide and tirzepatide. Compounded drugs are not FDA-approved, which means no one has reviewed their safety, effectiveness or manufacturing quality before sale. Our comparison of compounded, branded and research tirzepatide sets out what each route verifies.

A legitimate compounded prescription therefore comes with a reason it is compounded rather than branded, a pharmacy you can verify, and a label that says what it is.

A worked example: a GLP-1 prescription done properly

The GLP-1 weight-loss drugs are the peptides most often prescribed by telehealth, and their labels show what a careful prescriber has to check. Both Wegovy (semaglutide) and Zepbound (tirzepatide) carry a boxed warning about thyroid C-cell tumours seen in rodents, and both are contraindicated in people with a personal or family history of medullary thyroid cancer or the inherited syndrome MEN 2 (drug labels) ⁵. A legitimate prescriber asks about that history before writing anything.

The labels also list warnings that shape the consultation: inflammation of the pancreas, gallbladder disease, kidney injury from dehydration during vomiting or diarrhoea, low blood sugar in people taking other diabetes drugs, diabetic eye disease, and a risk of inhaling stomach contents during anaesthesia or deep sedation, which is why surgeons and anaesthetists need to know (drug labels) ⁵. Each one is a question a proper intake form or video visit should cover.

Then there is the schedule. Wegovy starts at 0.25 mg once a week for four weeks and steps up every four weeks to a usual maintenance dose of 2.4 mg; Zepbound starts at 2.5 mg weekly for four weeks and rises in 2.5 mg steps to a maintenance dose of 5, 10 or 15 mg. The Wegovy label advises delaying a step by four weeks if a dose is not tolerated (drug labels) ⁵. A legitimate service plans those check-ins; one that ships the top dose first, or the same dose month after month without asking how you are, is not following the label.

If you have already bought from an unverified source

Stop using the product until you have spoken to a clinician, and keep the vial, packaging and any paperwork, which help a doctor or pharmacist work out what it might be. Tell your doctor what you took, when and how much; it changes what they look for if you feel unwell. Severe symptoms after an injection, such as swelling of the face or throat, trouble breathing, severe abdominal pain or persistent vomiting, need emergency care.

FDA asks people who think they have bought a counterfeit or unsafe medicine to report it, and its BeSafeRx pages explain how (government guidance) ¹. If you want to continue treatment, a licensed clinician can tell you whether an approved drug suits you and how to switch safely, including at what dose to restart, since compounded and gray-market products may not contain what their labels claim (market surveillance study) ².

Peptides that never need a prescription

Not every product with "peptide" on the label is a drug. Skin creams containing Matrixyl, Argireline or copper peptides are cosmetics, and collagen peptide powders are foods or supplements. Neither needs a prescription. Cosmetics do not need FDA approval before sale, and the agency does not review them for effectiveness (government guidance) ⁶; supplements are not approved either. That is why these products can be sold freely, and also why their claims rest on the manufacturer's word.

The line is crossed when a product is meant to be injected, or is sold to treat a disease. An injectable "peptide" is a drug, whatever its seller calls it, and needs either an FDA approval or a lawful compounding route. A clinic that sells injectable copper peptide or Matrixyl is selling a drug without either, and our entries on GHK-Cu and palmitoyl pentapeptide-4 show how little human evidence lies behind even the topical uses.

The grey zone: once-approved and off-label peptides

Some peptides sit between the clear cases. Sermorelin is the usual example: it was approved in the US as Geref for children with growth hormone deficiency, as a diagnostic ampoule in 1990 and as treatment vials in 1997, and both products were later discontinued. FDA determined in 2013 that Geref was not withdrawn for reasons of safety or effectiveness, which matters for whether pharmacies may compound it; our sermorelin entry records those dates. A clinic offering sermorelin for adults who want to feel younger is therefore prescribing a compounded version of a discontinued children's drug for a use it was never approved for.

Off-label prescribing of approved drugs is legal and common in medicine, but it shifts the burden onto the prescriber to explain the evidence. A legitimate clinician will tell you plainly when a use is off-label and what supports it. One who presents an off-label or compounded peptide as if it were a standard, approved treatment for that purpose is not being straight with you.

Questions to ask before you pay

• Who is the prescriber, which state licenses them, and will I speak to them?
• Which pharmacy fills the prescription, and can I find it in my state board's licence lookup?
• Is the drug branded or compounded, and if compounded, why, and is it made under 503A or 503B?
• What tests do you need before starting, and how often will someone check in?
• What happens if I have side effects at night or on a weekend?

A legitimate provider answers all five without hesitation. Vague answers, or a push to pay before any of them is answered, are themselves the answer.

How it adds up (as of October 4, 2026)

A legitimate peptide prescription is a chain of verifiable steps: a clinician licensed in your state who assesses you, a pharmacy licensed by your state board with a pharmacist you can reach, and a label that names the drug and, for compounded products, says so. Telehealth does not change those requirements, and the Ryan Haight Act's in-person rule applies only to controlled substances, with its suspension extended through December 31, 2026. No prescription can turn an unapproved peptide into an approved one. If a provider cannot show you each link in that chain, the safest assumption is that one of them is missing, and the cheapest offer is usually where it is missing.

Frequently asked questions

Do you need a prescription for peptides?

For approved peptide drugs such as semaglutide or tirzepatide, yes. Unapproved peptides cannot legally be sold for human use, and a prescription does not change that.

Can I get a peptide prescription online?

Yes, from a telehealth clinician licensed in your state after a genuine assessment, filled by a licensed pharmacy. Avoid services that issue prescriptions from a checkout form.

How do I check an online pharmacy?

FDA's BeSafeRx guidance: it should require a prescription, be licensed by your state board of pharmacy, have a US address and phone number, and have a pharmacist available.

What should a compounded peptide label say?

Outsourcing-facility products must state 'This is a compounded drug' and name the facility and compounding date; all compounded labels should name the ingredient and strength.

Does the Ryan Haight Act apply to peptides?

Only to controlled substances, and its in-person requirement is suspended through December 31, 2026. Most peptide drugs, including GLP-1 medicines, are not controlled.

Related on Grey Peptides

• 12 questions to ask a peptide clinic
• Category 2, 503A and 503B explained
• Can a doctor prescribe BPC-157?
• Legal status checker

Sources

1. U.S. Food and Drug Administration. BeSafeRx: Know the Signs, and Considering an Online Pharmacy? Read October 4, 2026. Source
2. Ashraf, A. R., et al. (2024). Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study. J Med Internet Res, 26, e65440. PMID: 39509151
3. U.S. Food and Drug Administration. Text of the Compounding Quality Act: Federal Food, Drug, and Cosmetic Act section 503B(a)(10), outsourcing-facility label requirements. Read October 4, 2026. Source
4. Drug Enforcement Administration and Department of Health and Human Services. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, effective January 1 through December 31, 2026; read October 4, 2026.
5. Novo Nordisk. WEGOVY (semaglutide) US prescribing information, boxed warning and sections 2 and 5 (DailyMed, effective June 18, 2026); Eli Lilly. ZEPBOUND (tirzepatide) US prescribing information, boxed warning and sections 2 and 5 (DailyMed, effective August 28, 2026); read October 4, 2026.
6. U.S. Food and Drug Administration. FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated. Read October 4, 2026. Source

Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.